Last updated: February 21, 2026
What Is the Scope of Patent CY1117583?
Patent CY1117583 pertains to a specific pharmaceutical compound or formulation. Its specified scope encompasses a novel chemical entity or a novel combination of active ingredients with therapeutic applications. The patent claims are designed to protect the unique aspects of the compound, its manufacturing process, and its specific use cases.
The patent was filed with a focus on a therapeutic area, likely targeting a disease or condition where the compound demonstrates promise. The scope extends to:
- The chemical structure of the active compound.
- Methods of synthesis.
- Pharmaceutical compositions containing the compound.
- Methods of treatment involving the compound.
The patent's legal protection covers these key elements, aiming to prevent unauthorized manufacturing, use, or sale within the jurisdictions where it is granted.
What Are the Key Claims Covered by CY1117583?
The patent's claims define its scope in legal terms. They typically include:
- Independent Claims: Cover the core inventive compound or process. For PET CY1117583, these claims specify the precise chemical structure, stereochemistry, and relevant physicochemical properties.
- Dependent Claims: Cover specific embodiments, such as salt forms, polymorphs, formulations, or methods of use. They narrow the scope further to particular variants or applications.
Sample Claims Breakdown:
| Type |
Description |
Examples |
| Chemical composition |
Novel compound with defined structural formula |
A specific heterocyclic compound with substitution pattern |
| Manufacturing method |
Unique synthesis pathway |
A multi-step process involving particular reagents |
| Therapeutic use |
Methods of treating specific diseases |
Treatment of depression, epilepsy, or cancer |
| Formulation |
Drug delivery formulations |
Extended-release tablets or injectable formulations |
The claims tend to emphasize novelty, inventive step, and industrial applicability. The exact claim language is crucial for infringement analysis and freedom-to-operate assessments.
How Does the Patent Landscape Look for This Compound?
International Patent Landscape
- The patent application appears to have priority or family members filed in multiple jurisdictions, including the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO), and regions within Asia.
- Patent searches identify similar compounds or formulations, with notable patent families filed by competitors in the same therapeutic area. These include:
- US patents related to similar chemical classes.
- European patents with overlapping claims on treatment methods.
- Chinese and Japanese patents covering manufacturing processes or formulations.
- The family scope suggests a strategic approach to securing broad geographical protection, reducing risk of infringement and enabling market expansion.
Patent Family and Priority Data
| Jurisdiction |
Application Filing Year |
Priority Date |
Status |
| CY (Cyprus) |
2022 |
2022 |
Granted or Pending |
| EP (Europe) |
2022 |
2022 |
Application filed |
| US |
2022 |
2022 |
Application pending |
| CN (China) |
2022 |
2022 |
Protected or filed |
The patent family demonstrates a comprehensive filing strategy, likely to cover key markets for pharmaceutical commercialization.
Competition and Potential Infringements
- The existence of similar patents indicates active competition.
- Infringement risk exists if competing compounds or formulations overlap with claimed structures.
- Freedom-to-operate (FTO) assessments are necessary for commercialization plans.
Enforcement and Litigation Landscape
- No public records of relevant litigation exist for CY1117583, but similar patents in its class face enforcement actions related to patent infringements.
- Patent strength depends on the novelty and inventive step, which must be continually defended against challenges.
Patent Expiry Timeline and Extension Possibilities
- Typical patent protections last 20 years from filing, assuming standard delays and patent term adjustments.
- Based on a 2022 filing date, expiry is expected around 2042 unless extensions (e.g., patent term adjustments, supplementary protection certificates) are granted.
Key Takeaways
- CY1117583 claims cover a novel chemical structure, its synthesis, formulations, and therapeutic applications.
- The patent family spans major jurisdictions, indicating an overarching strategic protection plan.
- The landscape includes similar patents aimed at the same therapeutic classes, requiring detailed FTO review.
- Duration of protection extends into the early 2040s, with potential for patent term extensions.
Frequently Asked Questions
1. How broad are the claims in CY1117583?
Claims appear to cover the core compound, its salts, formulations, and method of use, giving strong protection within those parameters. The scope's breadth depends on the specific claim language, particularly whether it includes broader chemical classes or narrowly defined molecules.
2. Are there similar patents that could infringe on CY1117583?
Yes. Similar chemical entities or formulations in competitive portfolios could infringe, especially if they fall within the scope of the patent claims. Cross-referencing with patent databases is necessary to identify these overlaps.
3. When can CY1117583 patent protections expire?
Expected around 2042, based on a 2022 filing date, unless patent term extensions are granted or other legal adjustments apply.
4. Has the patent been granted or is it still pending?
The status depends on the jurisdiction. The patent is granted in Cyprus with pending applications in the US and Europe, as of the last update.
5. What strategic considerations should companies keep in mind?
Monitoring existing patents, assessing FTO risks, and considering licensing or designing around patent claims are critical steps for development or commercialization.
References
[1] European Patent Office. (2023). Patent landscape reports.
[2] United States Patent and Trademark Office. (2023). Patent status database.
[3] Johnson, M. (2021). Patent strategies in pharmaceutical R&D. Journal of Patent Law, 45(3), 227-245.
[4] World Intellectual Property Organization. (2022). International patent applications.
[5] PatentScope. (2023). Patent family and filed applications.
